Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1839505
PUBLISHER: QYResearch | PRODUCT CODE: 1839505
Global Nucleic Acid Drugs Market Insights, Forecast to 2031
PUBLISHED:
PAGES: 164 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global Nucleic Acid Drugs market is projected to grow from US$ 14636 million in 2024 to US$ 21722 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.43% during the forecast period.
The North America market for Nucleic Acid Drugs is estimated to increase from $ 8327.53 million in 2024 to reach $ 11827 million by 2031, at a CAGR of 6.4% during the forecast period of 2025 through 2031.
The China market for Nucleic Acid Drugs is estimated to increase from $ 81.1 million in 2024 to reach $ 1231.84 million by 2031, at a CAGR of 44.83% during the forecast period of 2025 through 2031.
The Europe market for Nucleic Acid Drugs is estimated to increase from $ 3316.94 million in 2024 to reach $ 6063.24 million by 2031, at a CAGR of 10.64% during the forecast period of 2025 through 2031.
The global key companies of Nucleic Acid Drugs include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc. In 2024, the global top five players had a share approximately 86.47% in terms of revenue.
Report Includes
This report presents an overview of global market for Nucleic Acid Drugs market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Nucleic Acid Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nucleic Acid Drugs revenue, market share and industry ranking of main companies, data from 2020 to 2024. Identification of the major stakeholders in the global Nucleic Acid Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Nucleic Acid Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc.
Market Segmentation
By Company
On Market Company
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- BioNTech
- Pfizer
- Moderna Therapeutics
- Jazz Pharmaceuticals
- Novo Nordisk
- AstraZeneca
- Astellas Pharma
On Pipeline Company
- CureVac
- Regulus Therapeutics
- ProQR
- Secarna
- MiNA Therapeutics
- Sylentis
- Arrowhead
- Silence Therapeutics
Segment by Type
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
Segment by Application
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
By Region
- North America
- United States
- Canada
- China
- Asia-Pacific
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Middle East
- Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nucleic Acid Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
- 1.2.2 Antisense Oligonucleotides (ASO)
- 1.2.3 siRNA
- 1.2.4 mRNA
- 1.3 Market by Application
- 1.3.1 Global Nucleic Acid Drugs Market Share by Application: 2020 VS 2024 VS 2031
- 1.3.2 Neuromuscular Diseases
- 1.3.3 hATTR
- 1.3.4 COVID-19
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Nucleic Acid Drugs Market Perspective (2020-2031)
- 2.2 Global Nucleic Acid Drugs Growth Trends by Region
- 2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2020 VS 2024 VS 2031
- 2.2.2 Nucleic Acid Drugs Market Size by Region (2020-2031)
- 2.3 Nucleic Acid Drugs Market Dynamics
- 2.3.1 Nucleic Acid Drugs Industry Trends
- 2.3.2 Nucleic Acid Drugs Market Drivers
- 2.3.3 Nucleic Acid Drugs Market Challenges
- 2.3.4 Nucleic Acid Drugs Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Nucleic Acid Drugs by Players
- 3.1.1 Global Nucleic Acid Drugs Revenue by Players (2020-2025)
- 3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2020-2025)
- 3.2 Global Nucleic Acid Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Nucleic Acid Drugs, Ranking by Revenue, 2023 VS 2024 VS 2025
- 3.4 Global Market Concentration Ratio
- 3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Drugs Revenue in 2024
- 3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served
- 3.6 Global Key Players of Nucleic Acid Drugs, Product and Application
- 3.7 Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2020-2025)
- 4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
- 5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2020-2025)
- 5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2026-2031)
6 North America
- 6.1 North America Nucleic Acid Drugs Market Size (2020-2031)
- 6.2 North America Market Size by Type
- 6.2.1 North America Nucleic Acid Drugs Market Size by Type (2020-2031)
- 6.2.2 North America Nucleic Acid Drugs Market Share by Type (2020-2031)
- 6.3 North America Market Size by Application
- 6.3.1 North America Nucleic Acid Drugs Market Size by Application (2020-2031)
- 6.3.2 North America Nucleic Acid Drugs Market Share by Application (2020-2031)
- 6.4 North America Market Size by Country
- 6.4.1 North America Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 6.4.2 North America Nucleic Acid Drugs Market Size by Country (2020-2031)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Nucleic Acid Drugs Market Size (2020-2031)
- 7.2 Europe Market Size by Type
- 7.2.1 Europe Nucleic Acid Drugs Market Size by Type (2020-2031)
- 7.2.2 Europe Nucleic Acid Drugs Market Share by Type (2020-2031)
- 7.3 Europe Market Size by Application
- 7.3.1 Europe Nucleic Acid Drugs Market Size by Application (2020-2031)
- 7.3.2 Europe Nucleic Acid Drugs Market Share by Application (2020-2031)
- 7.4 Europe Market Size by Country
- 7.4.1 Europe Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 7.4.2 Europe Nucleic Acid Drugs Market Size by Country (2020-2025)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
8 China
- 8.1 China Nucleic Acid Drugs Market Size (2020-2031)
- 8.2 China Market Size by Type
- 8.2.1 China Nucleic Acid Drugs Market Size by Type (2020-2031)
- 8.2.2 China Nucleic Acid Drugs Market Share by Type (2020-2031)
- 8.3 China Market Size by Application
- 8.3.1 China Nucleic Acid Drugs Market Size by Application (2020-2031)
- 8.3.2 China Nucleic Acid Drugs Market Share by Application (2020-2031)
9 Asia (excluding China)
- 9.1 Asia Nucleic Acid Drugs Market Size (2020-2031)
- 9.2 Asia Market Size by Type
- 9.2.1 Asia Nucleic Acid Drugs Market Size by Type (2020-2031)
- 9.2.2 Asia Nucleic Acid Drugs Market Share by Type (2020-2031)
- 9.3 Asia Market Size by Application
- 9.3.1 Asia Nucleic Acid Drugs Market Size by Application (2020-2031)
- 9.3.2 Asia Nucleic Acid Drugs Market Share by Application (2020-2031)
- 9.4 Asia Market Size by Region
- 9.4.1 Asia Nucleic Acid Drugs Market Size by Region: 2020 VS 2024 VS 2031
- 9.4.2 Asia Nucleic Acid Drugs Market Size by Region (2020-2031)
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Southeast Asia
- 9.4.6 India
- 9.4.7 Australia
10 Middle East, Africa, and Latin America
- 10.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size (2020-2031)
- 10.2 Middle East, Africa, and Latin America Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2020-2031)
- 10.2.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2020-2031)
- 10.3 Middle East, Africa, and Latin America Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2020-2031)
- 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
- 10.4 Middle East, Africa, and Latin America Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 10.4.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2020-2031)
- 10.4.3 Brazil
- 10.4.4 Mexico
- 10.4.5 Middle East
- 10.4.6 Africa
11 Key Players Profiles
- 11.1 Sarepta Therapeutics
- 11.1.1 Sarepta Therapeutics Company Details
- 11.1.2 Sarepta Therapeutics Business Overview
- 11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction
- 11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.1.5 Sarepta Therapeutics Recent Development
- 11.2 Ionis Pharmaceuticals
- 11.2.1 Ionis Pharmaceuticals Company Details
- 11.2.2 Ionis Pharmaceuticals Business Overview
- 11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction
- 11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.2.5 Ionis Pharmaceuticals Recent Development
- 11.3 Alnylam
- 11.3.1 Alnylam Company Details
- 11.3.2 Alnylam Business Overview
- 11.3.3 Alnylam Nucleic Acid Drugs Introduction
- 11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.3.5 Alnylam Recent Development
- 11.4 Biogen
- 11.4.1 Biogen Company Details
- 11.4.2 Biogen Business Overview
- 11.4.3 Biogen Nucleic Acid Drugs Introduction
- 11.4.4 Biogen Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.4.5 Biogen Recent Development
- 11.5 Nippon Shinyaku
- 11.5.1 Nippon Shinyaku Company Details
- 11.5.2 Nippon Shinyaku Business Overview
- 11.5.3 Nippon Shinyaku Nucleic Acid Drugs Introduction
- 11.5.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.5.5 Nippon Shinyaku Recent Development
- 11.6 Sobi
- 11.6.1 Sobi Company Details
- 11.6.2 Sobi Business Overview
- 11.6.3 Sobi Nucleic Acid Drugs Introduction
- 11.6.4 Sobi Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.6.5 Sobi Recent Development
- 11.7 Novartis
- 11.7.1 Novartis Company Details
- 11.7.2 Novartis Business Overview
- 11.7.3 Novartis Nucleic Acid Drugs Introduction
- 11.7.4 Novartis Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.7.5 Novartis Recent Development
- 11.8 BioNTech
- 11.8.1 BioNTech Company Details
- 11.8.2 BioNTech Business Overview
- 11.8.3 BioNTech Nucleic Acid Drugs Introduction
- 11.8.4 BioNTech Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.8.5 BioNTech Recent Development
- 11.9 Pfizer
- 11.9.1 Pfizer Company Details
- 11.9.2 Pfizer Business Overview
- 11.9.3 Pfizer Nucleic Acid Drugs Introduction
- 11.9.4 Pfizer Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.9.5 Pfizer Recent Development
- 11.10 Moderna Therapeutics
- 11.10.1 Moderna Therapeutics Company Details
- 11.10.2 Moderna Therapeutics Business Overview
- 11.10.3 Moderna Therapeutics Nucleic Acid Drugs Introduction
- 11.10.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.10.5 Moderna Therapeutics Recent Development
- 11.11 Jazz Pharmaceuticals
- 11.11.1 Jazz Pharmaceuticals Company Details
- 11.11.2 Jazz Pharmaceuticals Business Overview
- 11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Introduction
- 11.11.4 Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.11.5 Jazz Pharmaceuticals Recent Development
- 11.12 Novo Nordisk
- 11.12.1 Novo Nordisk Company Details
- 11.12.2 Novo Nordisk Business Overview
- 11.12.3 Novo Nordisk Nucleic Acid Drugs Introduction
- 11.12.4 Novo Nordisk Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.12.5 Novo Nordisk Recent Development
- 11.13 AstraZeneca
- 11.13.1 AstraZeneca Company Details
- 11.13.2 AstraZeneca Business Overview
- 11.13.3 AstraZeneca Nucleic Acid Drugs Introduction
- 11.13.4 AstraZeneca Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.13.5 AstraZeneca Recent Development
- 11.14 Astellas Pharma
- 11.14.1 Astellas Pharma Company Details
- 11.14.2 Astellas Pharma Business Overview
- 11.14.3 Astellas Pharma Nucleic Acid Drugs Introduction
- 11.14.4 Astellas Pharma Revenue in Nucleic Acid Drugs Business (2020-2025)
- 11.14.5 Astellas Pharma Recent Development
- 11.15 CureVac
- 11.15.1 CureVac Company Details
- 11.15.2 CureVac Business Overview
- 11.15.3 CureVac Nucleic Acid Drugs Introduction
- 11.15.4 CureVac Recent Development
- 11.16 Regulus Therapeutics
- 11.16.1 Regulus Therapeutics Company Details
- 11.16.2 Regulus Therapeutics Business Overview
- 11.16.3 Regulus Therapeutics Nucleic Acid Drugs Introduction
- 11.16.4 Regulus Therapeutics Recent Development
- 11.17 ProQR
- 11.17.1 ProQR Company Details
- 11.17.2 ProQR Business Overview
- 11.17.3 ProQR Nucleic Acid Drugs Introduction
- 11.17.4 ProQR Recent Development
- 11.18 Secarna
- 11.18.1 Secarna Company Details
- 11.18.2 Secarna Business Overview
- 11.18.3 Secarna Nucleic Acid Drugs Introduction
- 11.18.4 Secarna Recent Development
- 11.19 MiNA Therapeutics
- 11.19.1 MiNA Therapeutics Company Details
- 11.19.2 MiNA Therapeutics Business Overview
- 11.19.3 MiNA Therapeutics Nucleic Acid Drugs Introduction
- 11.19.4 MiNA Therapeutics Recent Development
- 11.20 Sylentis
- 11.20.1 Sylentis Company Details
- 11.20.2 Sylentis Business Overview
- 11.20.3 Sylentis Nucleic Acid Drugs Introduction
- 11.20.4 Sylentis Recent Development
- 11.21 Arrowhead
- 11.21.1 Arrowhead Company Details
- 11.21.2 Arrowhead Business Overview
- 11.21.3 Arrowhead Nucleic Acid Drugs Introduction
- 11.21.4 Arrowhead Recent Development
- 11.22 Silence Therapeutics
- 11.22.1 Silence Therapeutics Company Details
- 11.22.2 Silence Therapeutics Business Overview
- 11.22.3 Silence Therapeutics Nucleic Acid Drugs Introduction
- 11.22.4 Silence Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer 141
List of Tables
- Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
- Table 2. Global Nucleic Acid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
- Table 3. Global Nucleic Acid Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 4. Global Market Size by Region (2020-2025) & (US$ Million)
- Table 5. Global Market Size by Region (2026-2031) & (US$ Million)
- Table 6. Global Nucleic Acid Drugs Market Share by Region (2020-2025)
- Table 7. Global Nucleic Acid Drugs Market Share by Region (2026-2031)
- Table 8. Market Trends
- Table 9. Market Drivers
- Table 10. Market Challenges
- Table 11. Market Restraints
- Table 12. Global Nucleic Acid Drugs Revenue by Players (2020-2025) & (US$ Million)
- Table 13. Global Nucleic Acid Drugs Market Share by Players (2020-2025)
- Table 14. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2024)
- Table 15. Global Nucleic Acid Drugs Industry Ranking 2023 VS 2024
- Table 16. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2020-2025)
- Table 17. Global Key Players of Nucleic Acid Drugs, Headquarters and Area Served
- Table 18. Global Key Players of Nucleic Acid Drugs, Product and Application
- Table 19. Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry
- Table 20. Mergers & Acquisitions, Expansion Plans
- Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
- Table 22. Global Nucleic Acid Drugs Revenue Market Share by Type (2020-2025)
- Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
- Table 24. Global Nucleic Acid Drugs Revenue Market Share by Type (2026-2031)
- Table 25. Global Market Size by Application (2020-2025) & (US$ Million)
- Table 26. Global Nucleic Acid Drugs Revenue Market Share by Application (2020-2025)
- Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
- Table 28. Global Nucleic Acid Drugs Revenue Market Share by Application (2026-2031)
- Table 29. North America Market Size by Type (2020-2025) & (US$ Million)
- Table 30. North America Market Size by Type (2026-2031) & (US$ Million)
- Table 31. North America Market Size by Application (2020-2025) & (US$ Million)
- Table 32. North America Market Size by Application (2026-2031) & (US$ Million)
- Table 33. North America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
- Table 34. North America Market Size by Country (2020-2025) & (US$ Million)
- Table 35. North America Market Size by Country (2026-2031) & (US$ Million)
- Table 36. Europe Market Size by Type (2020-2025) & (US$ Million)
- Table 37. Europe Market Size by Type (2026-2031) & (US$ Million)
- Table 38. Europe Market Size by Application (2020-2025) & (US$ Million)
- Table 39. Europe Market Size by Application (2026-2031) & (US$ Million)
- Table 40. Europe Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
- Table 41. Europe Market Size by Country (2020-2025) & (US$ Million)
- Table 42. Europe Market Size by Country (2026-2031) & (US$ Million)
- Table 43. China Market Size by Type (2020-2025) & (US$ Million)
- Table 44. China Market Size by Type (2026-2031) & (US$ Million)
- Table 45. China Market Size by Application (2020-2025) & (US$ Million)
- Table 46. China Market Size by Application (2026-2031) & (US$ Million)
- Table 47. Asia Market Size by Type (2020-2025) & (US$ Million)
- Table 48. Asia Market Size by Type (2026-2031) & (US$ Million)
- Table 49. Asia Market Size by Application (2020-2025) & (US$ Million)
- Table 50. Asia Market Size by Application (2026-2031) & (US$ Million)
- Table 51. Asia Nucleic Acid Drugs Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 52. Asia Market Size by Region (2020-2025) & (US$ Million)
- Table 53. Asia Market Size by Region (2026-2031) & (US$ Million)
- Table 54. Middle East, Africa, and Latin America Market Size by Type (2020-2025) & (US$ Million)
- Table 55. Middle East, Africa, and Latin America Market Size by Type (2026-2031) & (US$ Million)
- Table 56. Middle East, Africa, and Latin America Market Size by Application (2020-2025) & (US$ Million)
- Table 57. Middle East, Africa, and Latin America Market Size by Application (2026-2031) & (US$ Million)
- Table 58. Middle East, Africa, and Latin America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
- Table 59. Middle East, Africa, and Latin America Market Size by Country (2020-2025) & (US$ Million)
- Table 60. Sarepta Therapeutics Company Details
- Table 61. Sarepta Therapeutics Business Overview
- Table 62. Sarepta Therapeutics Nucleic Acid Drugs Product
- Table 63. Sarepta Therapeutics Revenue (2020-2025) & (US$ Million)
- Table 64. Sarepta Therapeutics Recent Development
- Table 65. Ionis Pharmaceuticals Company Details
- Table 66. Ionis Pharmaceuticals Business Overview
- Table 67. Ionis Pharmaceuticals Nucleic Acid Drugs Product
- Table 68. Ionis Pharmaceuticals Revenue (2020-2025) & (US$ Million)
- Table 69. Ionis Pharmaceuticals Recent Development
- Table 70. Alnylam Company Details
- Table 71. Alnylam Business Overview
- Table 72. Alnylam Nucleic Acid Drugs Product
- Table 73. Alnylam Revenue (2020-2025) & (US$ Million)
- Table 74. Alnylam Recent Development
- Table 75. Biogen Company Details
- Table 76. Biogen Business Overview
- Table 77. Biogen Nucleic Acid Drugs Product
- Table 78. Biogen Revenue (2020-2025) & (US$ Million)
- Table 79. Biogen Recent Development
- Table 80. Nippon Shinyaku Company Details
- Table 81. Nippon Shinyaku Business Overview
- Table 82. Nippon Shinyaku Nucleic Acid Drugs Product
- Table 83. Nippon Shinyaku Revenue (2020-2025) & (US$ Million)
- Table 84. Nippon Shinyaku Recent Development
- Table 85. Sobi Company Details
- Table 86. Sobi Business Overview
- Table 87. Sobi Nucleic Acid Drugs Product
- Table 88. Sobi Revenue (2020-2025) & (US$ Million)
- Table 89. Sobi Recent Development
- Table 90. Novartis Company Details
- Table 91. Novartis Business Overview
- Table 92. Novartis Nucleic Acid Drugs Product
- Table 93. Novartis Revenue (2020-2025) & (US$ Million)
- Table 94. Novartis Recent Development
- Table 95. BioNTech Company Details
- Table 96. BioNTech Business Overview
- Table 97. BioNTech Nucleic Acid Drugs Product
- Table 98. BioNTech Revenue (2020-2025) & (US$ Million)
- Table 99. BioNTech Recent Development
- Table 100. Pfizer Company Details
- Table 101. Pfizer Business Overview
- Table 102. Pfizer Nucleic Acid Drugs Product
- Table 103. Pfizer Revenue (2020-2025) & (US$ Million)
- Table 104. Pfizer Recent Development
- Table 105. Moderna Therapeutics Company Details
- Table 106. Moderna Therapeutics Business Overview
- Table 107. Moderna Therapeutics Nucleic Acid Drugs Product
- Table 108. Moderna Therapeutics Revenue (2020-2025) & (US$ Million)
- Table 109. Moderna Therapeutics Recent Development
- Table 110. Jazz Pharmaceuticals Company Details
- Table 111. Jazz Pharmaceuticals Business Overview
- Table 112. Jazz Pharmaceuticals Nucleic Acid Drugs Product
- Table 113. Jazz Pharmaceuticals Revenue (2020-2025) & (US$ Million)
- Table 114. Jazz Pharmaceuticals Recent Development
- Table 115. Novo Nordisk Company Details
- Table 116. Novo Nordisk Business Overview
- Table 117. Novo Nordisk Nucleic Acid Drugs Product
- Table 118. Novo Nordisk Revenue (2020-2025) & (US$ Million)
- Table 119. Novo Nordisk Recent Development
- Table 120. AstraZeneca Company Details
- Table 121. AstraZeneca Business Overview
- Table 122. AstraZeneca Nucleic Acid Drugs Product
- Table 123. AstraZeneca Revenue (2020-2025) & (US$ Million)
- Table 124. AstraZeneca Recent Development
- Table 125. Astellas Pharma Company Details
- Table 126. Astellas Pharma Business Overview
- Table 127. Astellas Pharma Nucleic Acid Drugs Product
- Table 128. Astellas Pharma Revenue (2020-2025) & (US$ Million)
- Table 129. Astellas Pharma Recent Development
- Table 130. CureVac Company Details
- Table 131. CureVac Business Overview
- Table 132. CureVac Nucleic Acid Drugs Product
- Table 133. CureVac Recent Development
- Table 134. Regulus Therapeutics Company Details
- Table 135. Regulus Therapeutics Business Overview
- Table 136. Regulus Therapeutics Nucleic Acid Drugs Product
- Table 137. Regulus Therapeutics Recent Development
- Table 138. ProQR Company Details
- Table 139. ProQR Business Overview
- Table 140. ProQR Nucleic Acid Drugs Product
- Table 141. ProQR Recent Development
- Table 142. Secarna Company Details
- Table 143. Secarna Business Overview
- Table 144. Secarna Nucleic Acid Drugs Product
- Table 145. Secarna Recent Development
- Table 146. MiNA Therapeutics Company Details
- Table 147. MiNA Therapeutics Business Overview
- Table 148. MiNA Therapeutics Nucleic Acid Drugs Product
- Table 149. MiNA Therapeutics Recent Development
- Table 150. Sylentis Company Details
- Table 151. Sylentis Business Overview
- Table 152. Sylentis Nucleic Acid Drugs Product
- Table 153. Sylentis Recent Development
- Table 154. Arrowhead Company Details
- Table 155. Arrowhead Business Overview
- Table 156. Arrowhead Nucleic Acid Drugs Product
- Table 157. Arrowhead Recent Development
- Table 158. Silence Therapeutics Company Details
- Table 159. Silence Therapeutics Business Overview
- Table 160. Silence Therapeutics Nucleic Acid Drugs Product
- Table 161. Silence Therapeutics Recent Development
- Table 162. Research Programs/Design for This Report
- Table 163. Key Data Information from Secondary Sources
- Table 164. Key Data Information from Primary Sources
List of Figures
- Figure 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 2. Global Nucleic Acid Drugs Market Share by Type: 2024
- Figure 3. Global Nucleic Acid Drugs Market Share by Type: 2031
- Figure 4. Antisense Oligonucleotides (ASO) Features
- Figure 5. siRNA Features
- Figure 6. mRNA Features
- Figure 7. Global Nucleic Acid Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 8. Global Nucleic Acid Drugs Market Share by Application: 2024
- Figure 9. Global Nucleic Acid Drugs Market Share by Application: 2031
- Figure 10. Neuromuscular Diseases Case Studies
- Figure 11. hATTR Case Studies
- Figure 12. COVID-19 Case Studies
- Figure 13. Nucleic Acid Drugs Report Years Considered
- Figure 14. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
- Figure 15. Global Nucleic Acid Drugs Market Size, (US$ Million), 2020 VS 2025 VS 2031
- Figure 16. Global Nucleic Acid Drugs Market Share by Region: 2024 VS 2031
- Figure 17. Global Nucleic Acid Drugs Market Share by Region: 2024 VS 2031
- Figure 18. Global Nucleic Acid Drugs Market Share by Players in 2024
- Figure 19. The Top 5 Players Market Share by Nucleic Acid Drugs Revenue in 2024
- Figure 20. The Top 10 Players Market Share by Nucleic Acid Drugs Revenue in 2024
- Figure 21. North America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 22. North America Nucleic Acid Drugs Market Share by Type (2020-2031)
- Figure 23. North America Nucleic Acid Drugs Market Share by Application (2020-2031)
- Figure 24. North America Nucleic Acid Drugs Market Share by Country (2020-2031)
- Figure 25. United States Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 26. Canada Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 27. Europe Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 28. Europe Nucleic Acid Drugs Market Share by Type (2020-2031)
- Figure 29. Europe Nucleic Acid Drugs Market Share by Application (2020-2031)
- Figure 30. Europe Nucleic Acid Drugs Market Share by Country (2020-2031)
- Figure 31. Germany Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 32. France Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 33. U.K. Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 34. Italy Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 35. Russia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 36. China Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 37. China Nucleic Acid Drugs Market Share by Type (2020-2031)
- Figure 38. China Nucleic Acid Drugs Market Share by Application (2020-2031)
- Figure 39. Asia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 40. Asia Nucleic Acid Drugs Market Share by Type (2020-2031)
- Figure 41. Asia Nucleic Acid Drugs Market Share by Application (2020-2031)
- Figure 42. Asia Nucleic Acid Drugs Market Share by Region (2020-2031)
- Figure 43. Japan Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 44. South Korea Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 45. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 46. India Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 47. Australia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 48. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 49. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2020-2031)
- Figure 50. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2020-2031)
- Figure 51. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million)
- Figure 52. Brazil Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 53. Mexico Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 54. Middle East Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 55. Africa Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 56. Bottom-up and Top-down Approaches for This Report
- Figure 57. Data Triangulation
- Figure 58. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.